Researchers at Cornell have developed a way to analyze how individual immune cells react to the bacteria that cause tuberculosis. It could pave the way for new vaccine strategies and provide insights into fighting other infectious diseases.
A Michigan State University researcher is leading an international team of scientists to develop a low-cost, practical biopolymer dressing that helps heal these wounds.
The July 30 virtual conference is part of a three-year grant to train clinicians to prescribe medications to treat addiction.
In a new paper in Ethics & International Affairs, Binghamton University Professor of Philosophy Nicole Hassoun first considers existing proposals for equitable vaccine allocation focusing on the COVID-19 Vaccines Global Access (COVAX) facility. She then argues that to better promote…
Scientists at Oak Ridge National Laboratory and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in medicine, industry and agriculture.
Conversations between seriously ill people, their families and palliative care specialists lead to better quality-of-life. Understanding what happens during these conversations – and how they vary by cultural, clinical, and situational contexts – is essential to guide healthcare communication improvement efforts. To gain true understanding, new methods to study conversations in large, inclusive, and multi-site epidemiological studies are required. A new computer model offers an automated and valid tool for such large-scale scientific analyses.
How common COVID-19 is among infants may depend on the degree of the pandemic virus circulating in a community, a new study finds.
Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.
A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers. The team of engineers, scientists and physicians also conducted a pilot study on porcine hearts, with promising results.
They describe their work in the June 18, 2021 issue of Nature Communications.
The Food and Drug Administration on June 7 approved Aducanumab, which will carry the brand name Aduhelm, as the first new treatment for Alzheimer’s disease in nearly 20 years. Dr. Jeffrey L. Cummings, UNLV research professor and leading expert on Alzheimer’s clinical trials, calls…
Researchers at the Helsinki Graduate School of Economics have found that the Pfizer-BioNTech and Moderna Covid-19 vaccines protect both vaccinated individuals and their unvaccinated adult household members against SARS-CoV-2 infections. The study, not yet peer-reviewed, used Finnish administrative datasets to examine the link between mRNA-based Covid-19 vaccines and infection risk among vaccinated individuals as well as their unvaccinated family members.
Jack E. Dixon, whose distinguished and varied 48-year career ranged from helping reveal how cells communicate to becoming a renowned scientific leader at UC San Diego School of Medicine and Howard Hughes Medical Institute, is retiring.
Irvine, Calif., May 21, 2021 – A record of medicine utilization patterns assembled by an interdisciplinary team of researchers at the University of California, Irvine and the UC San Diego School of Medicine reveals the thought, care and scientific rigor clinicians at UC Health medical centers applied in their treatment of patients with COVID-19 in 2020.
NYU Langone Health appointed nationally renowned biotech and technology innovation expert as new vice president for Technology Opportunity Ventures.
NYU Grossman School of Medicine held a virtual graduation ceremony celebrating the accomplishments of 121 new physicians.
Several innovative, minimally invasive techniques used over the past 12 months to improve Carter’s health — including a first-of-its-kind procedure performed in the United States — means he can finally go home.
FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation
Irvine, Calif., May 5, 2021 – If you haven’t had knee surgery, you may have a friend or relative who has. But do you know anyone who has had an operation on their jaw? Although the temporomandibular joint is crucial to speaking, chewing and even breathing, treatments for TMJ disorders are far less common than those for the knee.
A new paper from the University of Georgia suggests that unconscious biases in the health care system may have influenced how individuals with intellectual disabilities were categorized in emergency triage protocols.
When Melodee Lasky joined Rutgers University 19 years ago, behavioral and mental health services were scattered across the individual colleges with little coordination. Psychiatry and the Alcohol and Other Drug Assistance Program were part of student health, but counseling services were separated and college-affiliated. Lasky, a physician who recognized the connection between physical and emotional wellness, recommended that mental and behavioral health be integrated within the framework of student health. That led to the creation of CAPS – Counseling, Alcohol and Other Drug Assistance Program & Psychiatric Services – a program that helps about 4,500 students each year.
Researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have designed a completely novel potential treatment for COVID-19: nanoparticles that capture SARS-CoV-2 viruses within the body and then use the body’s own immune system to destroy it.
New Brunswick, N.J. (April 20, 2021) – Rutgers University–New Brunswick allergy specialist Leonard Bielory is available for interviews on the spring allergy season in New Jersey. “One can expect a brisk allergy season this year since we had a lot…
Hertz Fellow Nevada Sanchez created the Butterfly iQ+, the world’s first handheld whole-body ultrasound system.
Irvine, Calif., March 24, 2021 – Vaccines are here, but as COVID-19 cases continue and variants spread, researchers need easy access to a wide variety of data to better understand the disease. Led by the University of California, Irvine, UC hospitals have received a $500,000 grant from the National Institutes of Health to make this possible.
Scientists at Berkeley Lab have demonstrated how to image samples of heavy elements as small as a single nanogram. The new approach will help scientists advance new technologies for medical imaging and cancer therapies.
Zea Borok, MD, has been named chair of the Department of Medicine at University of California San Diego School of Medicine. Her first day is April 1, 2021.
Renowned scientists—including Nobel laureates, research pioneers and celebrated educators—will speak at the virtual Experimental Biology (EB) 2021 meeting, to be held April 27–30. Bringing together thousands of life scientists in one interdisciplinary community, EB showcases the latest advances in anatomy, biochemistry, molecular biology, investigative pathology, pharmacology and physiology.
With topics ranging from the food we eat, the air we breathe, and the land we dwell on to the health of our body and mind, and the well-being of all things in the universe, this is a program that is for everyone and anyone. So, stay tuned and listen LIVE on Chula Radio Plus
Front Line COVID-19 Critical Care Alliance to Convene Global Panel of Leading Experts to Discuss the Latest Research on Preventing and Treating COVID-19 with Ivermectin
Leaders in biomedical informatics and medicine discuss ways to optimize the integration of AI in clinical medicine
A team of UNLV neuroscientists are uncovering how psychedelics affect brain activity. Their work, published recently in Nature: Scientific Reports, shows a strong connection in rodent models between brain activity and behaviors resulting from psychedelic treatment, a step forward in the quest to better understand their potential therapeutic effects.
ASME’s VisualizeMED: Modeling and Simulation in Medicine will take place on April 14-15, 2021. This two-day virtual event is enabling the transformation of modeling and simulation in medicine by bringing together industry experts of technology and masters of technique who are effectively implementing it with the goal to increase the application and adoption on a global scale.
Hospital also Ranked #1 Regionally in New York City and #7 in the U.S.
The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.
A team of researchers from Finland and Germany have found a way to study the endonuclease-driven digestion of drug-loaded DNA nanostructures in real time. As the team investigated the binding of anti-cancer drug doxorubicin (Dox) to the DNA structures in great detail, they discovered that the majority of previous studies have vastly overestimated the Dox loading capacity of DNA origami.
Complimentary press passes are now available for the virtual Experimental Biology (EB) 2021 meeting, to be held April 27–30. EB is the annual meeting of five scientific societies bringing together thousands of scientists and 25 guest societies in one interdisciplinary community.
Nick Pullen, Ph.D., an associate professor of Biological Sciences at the University of Northern Colorado (UNC), provides expertise regarding the topic of COVID-19 vaccinations and immunity. Pullen’s research centers around the body’s immune response, specifically chronic inflammation, asthma and allergies.…
Avacopan, which targets a receptor that attracts the cells that cause inflammation, was shown to be more effective at keeping patients in remission for a year than prednisone
Irvine, Calif., Feb. 16, 2021 — A radioactive bone cement that’s injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers. The study shows that this brachytherapy cement can be placed into spinal bones to directly irradiate tumors without harming the spinal cord, and the radioactive material will stay localized in the bones, which promises to virtually eliminate side effects.
Despite a Mexican government initiative launched in 2015 to improve access to prescription opioids among palliative care patients, the country has seen only a marginal increase in dispensing levels, and inequities in dispensing have left many of the nation’s poorest residents without comfort in their final days
Irvine, Calif., Feb. 9, 2021 — Monoclonal antibodies are showing promise for improving outcomes for COVID-19 patients, but when a hospital is already beyond capacity, administering them can be a challenge. As hospitalizations soared across California, clinicians with UCI Health created a system for delivering monoclonal antibodies that is keeping hospital beds available for patients with the greatest need.
The Federation of State Medical Boards (FSMB) released today a video recording of “Health Equity and Medical Regulation: How Disparities are Impacting U.S. Health Care Quality and Delivery and Why it Matters” – a symposium it hosted on January 26. The recording of the event is accessible for public viewing.
Irvine, Calif., Feb. 1, 2021 — Researchers from the University of California, Irvine and the University of Minnesota have found that an enriched diet and companionship can reduce pain in mice with sickle cell disease by increasing serotonin. They also discovered that duloxetine, an antidepressant that boosts serotonin levels, could be an alternative to opioids in treating chronic pain.
Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, is partnering with LifeBridge Health to launch 1501 Health, an incubator for healthcare startups. 1501 Health will provide investment and resources to help early-stage companies, located regionally or nationally, develop their healthcare solutions. Companies participating in the program will receive up to $100,000 in investment and have access to unique mentorship and support from payer and provider experts, along with networking and educational events with other startups, investors and stakeholders.
A new online platform to help mobilize volunteer health care professionals to treat patients during COVID-19 has officially launched, just as the number of cases, hospitalizations and deaths are increasing across the country. Provider Bridge (ProviderBridge.org), supports license portability by making it easier to connect volunteer health care professionals with state agencies and health care entities in order to quickly increase access to care for patients in rural and underserved communities.
A test developed by Berkeley Lab scientists can quickly and easily detect whether sperm cells are carrying chromosomal defects, an advance that will help men who have undergone cancer treatment father healthy children.
On January 8, 2021, the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory welcomed the first virtually visiting researchers to the Laboratory for BioMolecular Structure (LBMS), a new cryo-electron microscopy facility.
Integrating public health efforts and clinical care will address emerging global health challenges and ever-growing health disparities, according to a new Rutgers article.
Royalty Pharma today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System.
Irvine, Calif., Dec. 17, 2020 —University of California, Irvine health sciences researchers have created a machine-learning model to predict the probability that a COVID-19 patient will need a ventilator or ICU care. The tool is free and available online for any healthcare organization to use. “The goal is to give an earlier alert to clinicians to identify patients who may be vulnerable at the onset,” said Daniel S.